degradation 发表于 2025-3-23 11:48:13

Submitted on: 24 December 2013.
Revised on: 23 January 2014.
Accepted on: 15 February 2014.
Therapeutic Advances in Cardiovascular Disease

手段 发表于 2025-3-23 17:16:55

Submitted on: 25 January 1998.
Revised on: 20 February 1998.
Accepted on: 10 March 1998.
Therapeutic Advances in Cardiovascular Disease

潜伏期 发表于 2025-3-23 21:25:14

Submitted on: 06 May 2016.
Revised on: 08 June 2016.
Accepted on: 22 June 2016.
Therapeutic Advances in Cardiovascular Disease

贪婪性 发表于 2025-3-24 00:01:35

Submitted on: 29 October 2003.
Revised on: 18 November 2003.
Accepted on: 26 November 2003.
Therapeutic Advances in Cardiovascular Disease

不妥协 发表于 2025-3-24 06:18:47

Submitted on: 07 January 2011.
Revised on: 30 January 2011.
Accepted on: 14 February 2011.
Therapeutic Advances in Cardiovascular Disease

erythema 发表于 2025-3-24 08:11:30

Submitted on: 18 July 2008.
Revised on: 31 August 2008.
Accepted on: 05 September 2008.
Therapeutic Advances in Cardiovascular Disease

反抗者 发表于 2025-3-24 12:45:55

http://reply.papertrans.cn/3/295/29435/29435-17.png

最后一个 发表于 2025-3-24 15:25:37

http://reply.papertrans.cn/3/295/29435/29435-18.png

hemophilia 发表于 2025-3-24 20:51:37

http://reply.papertrans.cn/3/295/29435/29435-19.png

enhance 发表于 2025-3-25 03:15:13

http://reply.papertrans.cn/3/295/29435/29435-20.png
页: 1 [2] 3 4
查看完整版本: ESCI期刊Therapeutic Advances in Cardiovascular Disease 2024/2025影响因子:2.649 (THER ADV CARDIO DIS) (1753-9447). (CARDIAC &